Table 2 Comparison by functional outcome for patients with intracerebral hemorrhage and ischemic stroke
From: Association between plasma levels of hyaluronic acid and functional outcome in acute stroke patients
| Â | Intracerebral hemorrhage | Ischemic stroke | ||||
|---|---|---|---|---|---|---|
|  | mRS ≤2* (n = 23) | mRS > 2 (n = 20) | P | mRS ≤2* (n = 82) | mRS > 2 (n = 81) | P |
Age (years) | 54.2 ± 12.9 | 66.8 ± 13.9 | 0.004 | 62.6 ± 14.0 | 68.3 ± 12.4 | 0.007 |
Male | 15 (65.2) | 13 (65) | 1.000 | 64 (78.0) | 47 (58.0) | 0.007 |
Body mass index (kg/m2) | 25.1 ± 3.1 | 22.6 ± 3.8 | 0.023 | 25.9 ± 3.8 | 25.5 ± 3.7 | 0.528 |
Diabetes mellitus | 8 (34.7) | 2 (10.0) | 0.076 | 30 (36.6) | 37 (45.7) | 0.267 |
Hypertension | 21 (91.3) | 18 (90.0) | 1.000 | 53 (64.6) | 66 (81.5) | 0.021 |
Hyperlipidemia | 3 (13.0) | 6 (30.0) | 0.263 | 25 (30.5) | 28 (34.6) | 0.618 |
Atril fibrillation | 1 (4.3) | 1 (5.0) | 1.000 | 17 (20.7) | 25 (30.9) | 0.155 |
History of stroke | 3 (13.0) | 4 (20.0) | 0.687 | 10 (12.2) | 26 (32.1) | 0.002 |
WBC (103/μl) | 10.2 ± 4.4 | 10.3 ± 2.8 | 0.860 | 8.3 ± 2.8 | 9.3 ± 4.0 | 0.050 |
Hemoglobin | 14.9 ± 1.3 | 13.0 ± 4.4 | 0.057 | 14.6 ± 3.7 | 13.9 ± 1.9 | 0.173 |
Glucose (mg/dl) | 137.3 ± 59.2 | 113.5 ± 32.3 | 0.117 | 145.5 ± 61.9 | 148.8 ± 55.8 | 0.723 |
Creatinine (mg/dl) | 1.2 ± 0.7 | 1.1 ± 0.4 | 0.492 | 1.2 ± 1.0 | 1.3 ± 0.9 | 0.356 |
NIHSS | 9.7 ± 5.5 | 17.6 ± 7.6 | <0.001 | 5.1 ± 5.8 | 13.1 ± 7.4 | <0.001 |
Systolic blood pressure (mmHg) | 184.1 ± 44.5 | 190.1 ± 38.2 | 0.640 | 157.9 ± 31.8 | 160.8 ± 32.7 | 0.565 |
HA < 48 hours (ng/ml) | 202.7 ± 134.1 | 310.1 ± 225.9 | 0.061 | 195.9 ± 164.0 | 226.0 ± 242.6 | 0.356 |
HA 48 to 72 hours (ng/ml) | 271.1 ± 226.8 | 879.6 ± 1594.7 | 0.077 | 206.1 ± 304.2 | 379.2 ± 698.0 | 0.053 |